Prior to this appointment, Mr. Hess served as InVivo’s director of product development, a position he has held since February. Before joining InVivo, he spent eight years at Stryker developing biomaterial technologies for the orthopedic market. At Stryker, he was instrumental in leading multiple product development teams through the FDA process and developing HydroSet.
More Articles on Orthopedic Devices:
US Soft Tissue Solutions to Grow to $2B
Study: MoM Hip Implants Not Linked to Cancer After 7 Years
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
